Chemotherapy-induced peripheral neuropathy (CIPN) represents one of the most prevalent
and potentially disabling side effects due to the use of anticancer drugs, one of the primary …

Problem statement: Chemotherapy-induced peripheral neuropathy (CIPN) is a widespread
and potentially disabling side effect of various anticancer drugs. In spite of the intensive …

Purpose Paclitaxel-induced peripheral neuropathy (PIPN) constitutes a refractory and
progressive adverse consequence of paclitaxel treatment, causing pain and sensory …

Chemotherapy induced peripheral neuropathy (CIPN), a toxic side effect of some cancer
treatments, negatively impacts patient outcomes and drastically reduces survivor's quality of …

Neuropathic pain (NP) is a chronic pain disorder arising from somatosensory nervous
system impairment. Extensive evidence supports the notion that the gut microbiota (GM) is …

Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory
nervous system and affects 7–10% of the worldwide population. Neuropathic pain can be …

Background Gut microbiota has been found involved in neuronal functions and neurological
disorders. Whether and how gut microbiota impacts chronic somatic pain disorders remain …

Recently, a growing body of evidence has emerged regarding the interplay between
microbiota and the nervous system. This relationship has been associated with several …

Chemotherapy-induced peripheral neuropathy (CIPN) is a painful and debilitating side effect
of cancer chemotherapy with an unclear pathogenesis. Consequently, the available …

Chemotherapy-induced pain is a dose-limiting condition that affects 30% of patients
undergoing chemotherapy. We found that gut microbiota promotes the development of …